Cutera (NASDAQ:CUTR) Now Covered by StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued on Monday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Stock Up 2.2 %

CUTR stock opened at $0.46 on Monday. The firm has a market cap of $9.29 million, a price-to-earnings ratio of -0.07 and a beta of 1.31. The company’s fifty day simple moving average is $0.40 and its 200 day simple moving average is $0.76. Cutera has a 12-month low of $0.28 and a 12-month high of $4.81.

Institutional Investors Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Squarepoint Ops LLC raised its holdings in Cutera, Inc. (NASDAQ:CUTR) by 164.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 113,964 shares of the medical device company’s stock after buying an additional 70,870 shares during the quarter. Squarepoint Ops LLC owned 0.57% of Cutera worth $172,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 90.70% of the company’s stock.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.